Cancer
Malignant Colon Neoplasm
CI-CAN-00007995Explore in graph →
Top-level225 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007995Explore in graph →
Clinical trials
1,197 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (139)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | completed | Phase 3 | 2,710 | National Cancer Institute (NCI)NIH | 1 | Jul 30, 2019 | clinicaltrials |
| NCT04035096 | The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients | unknown | Phase 1 / Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Jul 29, 2019 |
| clinicaltrials |
| NCT02430948 | Improving Compliance With Medical Testing Guidelines | completed | N/A | 218 | Beth Israel Medical CenterOTHER | 1 | Jul 26, 2019 | clinicaltrials |
| NCT04031963 | Novel Biophotonics Methodology for Colon Cancer Screening(BRP) | completed | — | 857 | Endeavor HealthOTHER | 1 | Jul 25, 2019 | clinicaltrials |
| NCT03479645 | Serial SMS Reminders and an Opt-out Mailed FIT Kits to Improve Colorectal Screening Participation: A Single Center RCT | completed | N/A | 440 | University of PennsylvaniaOTHER | 1 | Jul 22, 2019 | clinicaltrials |
| NCT01890213 | Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer | completed | Phase 1 | 12 | Duke UniversityOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT02973672 | Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas | completed | Phase 1 / Phase 2 | 75 | SurgimabINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT00534053 | Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial | completed | N/A | 775 | University of California, San DiegoOTHER | 1 | Jul 17, 2019 | clinicaltrials |
| NCT00126867 | Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment | terminated | — | 29 | AHS Cancer Control AlbertaOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT04005118 | Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery(Microbiota) | unknown | — | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT03334383 | Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery(SPONGE) | unknown | N/A | 188 | St. Antonius HospitalOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT02266355 | Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction | completed | Phase 1 | 9 | Yale UniversityOTHER | 1 | May 30, 2019 | clinicaltrials |
| NCT01547845 | Cancer Symptom Data From Multiple Treatment Centers | completed | — | 2,517 | National Cancer Institute (NCI)NIH | 1 | May 28, 2019 | clinicaltrials |
| NCT01092481 | Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy | unknown | Phase 3 | 1,580 | Samsung Medical CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT01472601 | A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile | unknown | — | 2,660 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00354705 | Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients | unknown | — | 200 | M.D. Anderson Cancer CenterOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT01985763 | Genistein in Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 13 | Sofya PintovaOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT01206530 | FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer | completed | Phase 1 / Phase 2 | 50 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT03064308 | The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery(POETold) | completed | N/A | 11 | University of NottinghamOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03139942 | Optical Polyp Testing for In Vivo Classification(OPTIC) | completed | N/A | 13 | Imperial College LondonOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT00645710 | Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery | completed | Phase 1 / Phase 2 | 16 | City of Hope Medical CenterOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT03210129 | Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients(MIPAClux) | completed | N/A | 25 | Luxembourg Institute of HealthOTHER_GOV | 1 | Mar 14, 2019 | clinicaltrials |
| NCT02314871 | Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery | completed | Phase 4 | 60 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Mar 13, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03422601 | Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin Treatment | unknown | — | 1,122 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02883790 | Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients | terminated | N/A | 3 | Helsinn Healthcare SAINDUSTRY | 1 | Feb 22, 2019 | clinicaltrials |
| NCT03068052 | Behavioral Economic Incentives and Cancer Health Risk Assessment | completed | N/A | 2,000 | University of PennsylvaniaOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT03072095 | Colorectal Cancer Screening in a Community Health Setting | completed | N/A | 281 | University of PennsylvaniaOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT03246438 | Choice Architecture and Colorectal Cancer Screening Outreach | completed | N/A | 423 | University of PennsylvaniaOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT03213444 | Impact of Adjuvant Chemotherapy in Patients With Colon Cancer | completed | N/A | 30 | University of Sao Paulo General HospitalOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02572414 | Men Together Making a Difference: Health Promotion for Black Men | completed | N/A | 302 | University of PennsylvaniaOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT03826446 | Laparoscopic Versus Open Complete Mesocolic Excision With Central Vascular Ligation in Right Colon Cancer | completed | N/A | 60 | Menoufia UniversityOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT02402036 | A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer | terminated | Phase 2 | 10 | Georgetown UniversityOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT03322176 | Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing | unknown | — | 200 | Data Collection Analysis Business ManagementOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03052335 | The Efficiency of Colon Capsule Endoscopy in Colon Cancer Screening | unknown | N/A | 230 | Military University Hospital, PragueOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03803891 | Endoscopic Full-Thickness Resection In Colon(EFTRICOM) | unknown | — | 65 | Fundació Institut Germans Trias i PujolOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT00903565 | A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint(PARSC) | unknown | — | 1,200 | AgendiaINDUSTRY | 12 | Jan 9, 2019 | clinicaltrials |
| NCT01923337 | Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | completed | Phase 1 | 17 | University of California, DavisOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT03176485 | Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors | completed | N/A | 45 | University of ArizonaOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT02655952 | Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients | completed | Phase 1 | 17 | WntResearch ABINDUSTRY | 2 | Dec 28, 2018 | clinicaltrials |
| NCT01560377 | Perfusion Assessment in Laparoscopic Left Anterior Resection(PILLAR II) | completed | Phase 1 | 147 | Novadaq Technologies ULC, now a part of StrykerINDUSTRY | 1 | Dec 11, 2018 | clinicaltrials |
| NCT00267787 | Molecular Genetic and Pathological Studies of Anal Tumors | terminated | — | 7 | Stanford UniversityOTHER | 1 | Dec 10, 2018 | clinicaltrials |
| NCT01775254 | The Inland Northwest Colon Cancer Survivor's Study | completed | — | 25 | Washington State UniversityOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT00923520 | A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Dec 5, 2018 | clinicaltrials |
| NCT02391727 | Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors(SYN004_Ph_1) | completed | Phase 1 | 10 | Synermore Biologics Co., Ltd.INDUSTRY | 1 | Nov 16, 2018 | clinicaltrials |
| NCT00257322 | Cellular Immune Augmentation in Colon and Rectal Cancer | completed | Phase 2 | 20 | University of California, IrvineOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT02966509 | Engagement of Patients With Advanced Cancer(EPAC) | completed | N/A | 213 | Stanford UniversityOTHER | 0 | Oct 31, 2018 | clinicaltrials |
| NCT00094809 | Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer | completed | Phase 2 | 252 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jul 30, 2019source: clinicaltrials